BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2505148)

  • 1. Amyloid urinary-tract calculi in patients on chronic dialysis.
    Watanabe K; Nakamura R; Kano S; Ohtake T; Hosoda Y; Saruta T
    Nephron; 1989; 52(4):334-7. PubMed ID: 2505148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-2 microglobulin in patients on peritoneal dialysis and hemodialysis.
    Scalamogna A; Imbasciati E; De Vecchi A; Castelnovo C; Pagliari B; De Cristofaro V; Ponticelli C
    Perit Dial Int; 1989; 9(1):37-40. PubMed ID: 2488178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavior of beta 2-microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD).
    Blumberg A; Bürgi W
    Clin Nephrol; 1987 May; 27(5):245-9. PubMed ID: 3297439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of pyonephrosis caused by a protein calculus in a patient on hemodialysis].
    Shibasaki N; Kanno T; Tsuji Y; Taki Y; Takeuchi H
    Hinyokika Kiyo; 2004 Sep; 50(9):625-7. PubMed ID: 15518128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating form of beta-2-microglobulin in dialysis patients.
    Gagnon RF; Somerville P; Thomson DM
    Am J Nephrol; 1988; 8(5):379-83. PubMed ID: 3071144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amyloidosis associated with chronic hemodialysis. The prognostic significance of beta 2-microglobulin changes in patients with terminal chronic kidney failure treated by repeated hemodialysis].
    Manasia M; Meseşan M; Gherman-Căprioară M; Malide D; Paţiu IM; Pârvu L; Vlăduţiu D; Spânu CS
    Med Interna; 1991; 43(1-2):129-34. PubMed ID: 1670118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients.
    Jadoul M; Garbar C; Vanholder R; Sennesael J; Michel C; Robert A; Noël H; van Ypersele de Strihou C
    Kidney Int; 1998 Sep; 54(3):956-9. PubMed ID: 9734623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of beta-2-microglobulin using continuous ambulatory peritoneal dialysis.
    Sethi D; Murphy CM; Brown EA; Müller BR; Gower PE
    Nephron; 1989; 52(4):352-5. PubMed ID: 2671763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular variants of beta 2-microglobulin in renal insufficiency.
    Vincent C; Dennoroy L; Revillard JP
    Biochem J; 1994 Feb; 298 ( Pt 1)(Pt 1):181-7. PubMed ID: 8129718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein components of amyloid-like kidney stones of chronic hemodialysis patients.
    Ozasa H; Suzuki T; Takahashi K; Ota K
    Nephron; 1989; 53(3):257-60. PubMed ID: 2677809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of serum and urinary beta 2 microglobulin in end-stage renal disease patients.
    Argilés A; Derancourt J; Jauregui-Adell J; Mion C; Demaille JG
    Nephrol Dial Transplant; 1992; 7(11):1106-10. PubMed ID: 1336137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of amyloid-like substance from beta-2-microglobulin in vitro. Role of serum amyloid P component: a preliminary study.
    Ono K; Uchino F
    Nephron; 1994; 66(4):404-7. PubMed ID: 8015642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis arthropathy, beta 2-microglobulin and the effect of dialyser membrane.
    Sethi D; Gower PE
    Nephrol Dial Transplant; 1988; 3(6):768-72. PubMed ID: 3147418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The unresolved problem of beta-2 microglobulin amyloid deposits in the intervertebral discs of long-term dialysis patients.
    Tsai TT; Kaliya-Perumal AK; Jenq CC; Niu CC; Ho NY; Lee TY; Lai PL
    J Orthop Surg Res; 2017 Dec; 12(1):194. PubMed ID: 29268797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
    Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
    Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deposition and removal of cutaneous beta 2-microglobulin.
    Spiegel DM; Costante N; Janiga AM; Haas M; Soltani K
    Am J Nephrol; 1992; 12(5):330-5. PubMed ID: 1489002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levels of plasma beta 2-microglobulin and deposits of amyloid substance in patients under chronic hemodialysis].
    Lillo-Ferez M; Dupommereulle C; Prieur P; Petrover M
    Nephrologie; 1986; 7(5):211. PubMed ID: 3547164
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urolithiasis in chronic renal failure with hemodialysis].
    Nutahara K; Oshi M; Higashihara E
    Nihon Rinsho; 1992 Jan; 50 Suppl():855-60. PubMed ID: 1578778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.